United States

NuPathe Inc (PATH)

Track

Ticker: PATH
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
BioAdvance Ventures L P Large shareholder
Transaction date
Sale
Price
437.42
Quantity 37,213 +45.2%
Value US$153,268
BioAdvance Ventures L P Large shareholder
Transaction date
Sale
Price
464.72
Quantity 25,289 +17.6%
Value US$3,540,583
BioAdvance Ventures L P Large shareholder
Transaction date
Sale
Price
177.76
Quantity 11,065 -20.3%
Value US$4,509,159
ROCHE ROBERT P JR Non-Executive Director
Transaction date
Purchase
Price
2.68
Quantity 10,000 +inf%
Value US$26,799
Hollingsworth Jane H Chief Executive Officer Executive Director
Transaction date
Purchase
Price
2.56
Quantity 20,000 +10.3%
Value US$51,286
Kurtzman Gary J Non-Executive Director
Transaction date
Purchase
Price
2.49
Quantity 7,500 +inf%
Value US$18,674
BV3 LLC Member of 10% owner group
Transaction date
Purchase
Price
10.00
Quantity 54,758 +7.2%
Value US$547,580
BV3 LLC Member of 10% owner group
Transaction date
Purchase
Price
10.00
Quantity 27,066 +6.3%
Value US$270,660
BVP GP LLC Large shareholder
Transaction date
Purchase
Price
10.00
Quantity 29,359 +2.1%
Value US$293,590
BVP GP LLC Large shareholder
Transaction date
Purchase
Price
10.00
Quantity 264,231 +23.2%
Value US$2,642,310
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2012-10-17 2012-10-17 S Sale BioAdvance Ventures L P Large shareholder
37,213 +45.2%
437.42
US$153,268 		37,213 +45.2% 437.42 US$153,268
2012-10-17 2012-10-16 S Sale BioAdvance Ventures L P Large shareholder
25,289 +17.6%
464.72
US$3,540,583 		25,289 +17.6% 464.72 US$3,540,583
2012-10-17 2012-10-15 S Sale BioAdvance Ventures L P Large shareholder
11,065 -20.3%
177.76
US$4,509,159 		11,065 -20.3% 177.76 US$4,509,159
2011-09-19 2011-09-15 B Purchase ROCHE ROBERT P JR Non-Executive Director
10,000 +inf%
2.68
US$26,799 		10,000 +inf% 2.68 US$26,799
2011-09-12 2011-09-09 B Purchase Hollingsworth Jane H

Chief Executive Officer

Executive Director
20,000 +10.3%
2.56
US$51,286 		20,000 +10.3% 2.56 US$51,286
2011-09-07 2011-09-07 B Purchase Kurtzman Gary J Non-Executive Director
7,500 +inf%
2.49
US$18,674 		7,500 +inf% 2.49 US$18,674
2010-08-13 2010-08-11 B Purchase BV3 LLC

Member of 10% owner group
54,758 +7.2%
10.00
US$547,580 		54,758 +7.2% 10.00 US$547,580
2010-08-13 2010-08-11 B Purchase BV3 LLC

Member of 10% owner group
27,066 +6.3%
10.00
US$270,660 		27,066 +6.3% 10.00 US$270,660
2010-08-13 2010-08-11 B Purchase BVP GP LLC Large shareholder
29,359 +2.1%
10.00
US$293,590 		29,359 +2.1% 10.00 US$293,590
2010-08-13 2010-08-11 B Purchase BVP GP LLC Large shareholder
264,231 +23.2%
10.00
US$2,642,310 		264,231 +23.2% 10.00 US$2,642,310
Explore more

More insider trading research around NuPathe Inc

More insider trades in United States
Insider trading in North America